Table 3 Wilcoxon signed-rank test result.
From: Hybrid strategy enhanced crayfish optimization algorithm for breast cancer prediction
Function | MSCOA vs. COA | MSCOA vs. DBO | MSCOA vs. SABO | MSCOA vs. GWO | MSCOA vs. WWPA | MSCOA vs. CDO | MSCOA vs. LPO | MSCOA vs. APO |
|---|---|---|---|---|---|---|---|---|
F1 | 1 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 |
F2 | 1.66E-11 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 |
F3 | 1 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 |
F4 | 4.57E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 |
F5 | 1 | 5.85E-09 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1 | 1.21E-12 | 1.21E-12 |
F6 | 0.022783 | 0.013894 | 1.64E-05 | 1.72E-12 | 1.72E-12 | 0.1608 | 1.72E-12 | 1.72E-12 |
F7 | 0.652 | 2.03E-09 | 0.0406 | 4.08E-11 | 3.02E-11 | 0.0024 | 3.02E-11 | 3.02E-11 |
F8 | 1 | 0.0216 | 1 | 1.90E-09 | 1.21E-12 | 1.21E-12 | 1.21E-12 | 1.21E-12 |
F9 | 1 | 1 | 3.94E-12 | 8.30E-13 | 1.21E-12 | 1.69E-14 | 1.21E-12 | 1.21E-12 |
F10 | 1 | 0.0216 | 0.3337 | 1.70E-08 | 1.21E-12 | 1.95E-09 | 1.21E-12 | 1.21E-12 |
F11 | 0.1453 | 6.01E-08 | 0.0963 | 6.72E-10 | 1.61E-10 | 8.48E-09 | 3.02E-11 | 3.02E-11 |
F12 | 0.0251 | 3.35E-08 | 5.61E-05 | 3.02E-11 | 3.02E-11 | 8.84E-07 | 0.25805 | 3.02E-11 |
F13 | 2.99E-11 | 1.45E-11 | 1.96E-10 | 0.015 | 3.02E-11 | 3.02E-11 | 3.02E-11 | 2.60E-11 |
F14 | 3.02E-11 | 2.89E-11 | 2.15E-10 | 1.17E-09 | 3.02E-11 | 1.41E-04 | 3.02E-11 | 5.18E-12 |
F15 | 8.89E-10 | 0.0026 | 0.0679 | 0.0724 | 2.03E-07 | 0.0877 | 2.67E-09 | 1.61E-10 |
F16 | 3.02E-11 | 5.51E-06 | 3.34E-11 | 0.1335 | 3.02E-11 | 1.55E-09 | 3.02E-11 | 1.21E-12 |
F17 | 3.59E-05 | 9.23E-07 | 2.25E-04 | 5.49E-11 | 0.025101 | 3.01E-07 | 0.0069724 | 1.14E-09 |
